CORONA Remedies Limited, a distinguished name in India’s pharmaceutical industry, has announced an ambitious commitment of ₹25 crore for Corporate Social Responsibility (CSR) initiatives over the next five years. This landmark declaration was made during the company’s 20th-anniversary celebration, emphasizing its focus on enhancing healthcare access and creating a meaningful societal impact.

Celebrating two decades of serving millions across India, Dr. Kirtikumar Mehta, Chairperson of CORONA Remedies Limited, expressed pride in the company’s renewed CSR focus. “This milestone reflects our vision of delivering quality medicines while fostering meaningful change in the communities we serve. We are proud to strengthen our focus on societal well-being with a ₹25 crore pledge towards CSR initiatives,” he remarked. The initial phase of this commitment saw the company extend support to 20 NGOs across Gujarat and Maharashtra.

Supporting Communities Through Actionable CSR

As part of its anniversary celebrations, CORONA Remedies provided substantial donations to 20 NGOs, including esteemed organizations such as Jivan Dhara Old Age Home in Ahmedabad, Manav Jyot Public Charitable Trust in Mumbai, and Shree Pragnachakshu Mahila Seva Kunj in Surendranagar. This effort underscores the company’s dedication to fostering a brighter, more equitable future through impactful community engagement.

A Legacy of Growth and Contribution

Established in 2004, CORONA Remedies has grown exponentially, offering over 65 brands across therapeutic areas such as Cardiology, Diabetology, Neurology, Pain Management, and Women’s Healthcare. Financially, the company has achieved remarkable milestones, surpassing ₹100 crore in revenue in FY 2013 and reaching ₹1322 crore as of November 2024, according to Pharmatrac MAT data.

Commitment to ESG Standards

CORONA Remedies has consistently demonstrated its commitment to Environmental, Social, and Governance (ESG) principles. The company’s operations are environmentally sustainable, maintaining zero carbon emissions while expanding solar capacity to enhance renewable energy usage. Over the last decade, CORONA has hosted numerous blood donation drives, collecting 1,350 units of blood and earning accolades such as the “Gujarat Nu Gaurav” award for its community initiatives.

Socially, the company actively supports emerging sports talents and conducts extensive community service to promote health awareness. These efforts are complemented by strict governance practices that ensure product quality and transparency. CORONA’s adoption of advanced traceability technologies further safeguards its products against counterfeiting, reinforcing its commitment to ethical business practices.

Also Read: India’s Journey to Universal Health Coverage: Achievements, Challenges, and Opportunities

Vision for the Future

Through its multifaceted initiatives, CORONA Remedies continues to champion its mission of “Good Health For All.” The company’s ₹25 crore CSR pledge marks a significant step towards creating a sustainable and inclusive future, reflecting its dedication to societal welfare and healthcare excellence.

This announcement not only celebrates CORONA’s 20 years of achievements but also sets the stage for its continued role as a catalyst for positive change in the healthcare landscape.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!